Open Government Portal

Found 2972 records

The safety of all vaccines, including Gardasil, is under continuous monitoring by Health Canada and the Public Health Agency of …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review GARDASIL all vaccines side-effects after vaccination Quadrivalent Human Papillomavirus Recombinant Vaccine assessing general safety Autoimmune Cardiovascular Diseases body's own-defence-system attacks-itself autoimmune diseases diseases affecting ...

In 2016, Health Canada reviewed the risk of gadolinium build-up in the brain and potential neurological side effects in light …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Gadolinium assessing risk gadolinium build-up brain brain-and-nervous system neurological side effects

In 2014, the product information for gabapentin products was updated to warn about the risk of serious breathing problems (respiratory …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Gabapentin assessing potential risk Serious Breathing Problems respiratory depression used with an-opioid

Health Canada started a safety review following a review done by the FDA on systemic (taken by mouth or by …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Fluoroquinolones assessing risk persistent-and-disabling side effects

This safety review was carried out as a follow-up assessment on the potential risk of suicidality with the use of …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Finasteride assessing risk of Suicidal Suicidal Thoughts-and-Behaviour Suicidality

Health Canada reviewed the risk of potential serious muscle-related side effects with finasteride use because of reports in which these …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Finasteride assessing potential risk Muscle-Related Side Effects Propecia and Proscar rhabdomyolysis pain in muscles breakdown of muscle-tissue muscle proteins kinase enzymes ...

A safety review was carried out by Health Canada to evaluate the risk of harmful side effects in areas of …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review EYLEA aflibercept assessing risk of side-effects Outside the Eye systemic side effects systemic toxicity

A safety review was conducted to evaluate the potential link between Abilify and Abilify Maintena (aripiprazole) and certain behaviours where …

Record Modified: May 8, 2024
Record Released: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: summary safety review ABILIFY ABILIFY MAINTENA aripiprazole impulse control behaviours uncontrollable gambling pathological gambling sexual behaviours hypersexuality evaluating the risk

This safety review was carried out by Health Canada after the publication of case reports of IAS (insulin autoimmune syndrome) …

Record Modified: May 8, 2024
Record Released: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Alpha Lipoic Acid assessing potential risk Low Blood Sugar Hypoglycemic Episodes insulin autoimmune syndrome oral alpha lipoic-acid body's own defence-system insulin

Health Canada carried out this safety review when it became aware that the FDA was investigating the risk of angle-closure …

Record Modified: May 8, 2024
Record Released: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Antidepressants assessing potential risk serious Eye Disorder Angle-Closure Glaucoma antidepressant use eye-fluid-drainage is blocked eye pain blurred vision permanent vision loss